L26/O-296 Impact of thyroid autoimmunity on reproductive outcomes after intra uterine insemination (IUI) and subsequent IVF/ICSI in euthyroid infertile women: a retrospective cohort study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.294 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von L. Van Loendersloot und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Does thyroid autoimmunity influence ongoing pregnancy rates, miscarriage rates and time to pregnancy after IUI and subsequent IVF/ICSI in euthyroid infertile women? Summary answer There was no association between thyroid autoimmunity and ongoing pregnancy,miscarriage rates after IUI and time to pregnancy after IUI and IVF/ICSI in euthyroid infertile women What is known already Thyroid autoimmunity, defined as the presence of thyroid peroxidase antibodies (TPO-Abs), is associated with adverse fertility and pregnancy outcomes following both natural conception and ART. In women with normal thyroid function, thyroid autoimmunity has been suggested to be associated with infertility, reduced pregnancy rates, recurrent implantation failure, early pregnancy loss, and adverse obstetric outcomes. However, the available evidence remains inconsistent. In particular, data on the impact of thyroid autoimmunity on reproductive outcomes after intrauterine insemination (IUI), as well as on time to pregnancy following IUI and subsequent IVF/ICSI, are scarce. Study design, size, duration We conducted a retrospective cohort study including 687 euthyroid infertile women with an indication for IUI treated at Amsterdam UMC between January 2020 and December 2023. Of these, 115 women (16.7%) were TPO-Abs positive and 572 (83.3%) were TPO-Abs negative. Women who did not conceive after a maximum of six IUI cycles were offered IVF/ICSI in accordance with Dutch national guidelines Participants/materials, setting, methods Women with TPO-Abs ≥60 kU/L were classified as positive and <60 kU/L as negative. Baseline characteristics and data on IUI and eventual subsequent IVF/ICSI were collected. Primary outcomes were ongoing pregnancy and miscarriage after IUI; secondary outcome was time to pregnancy after IUI and IVF/ICSI. Associations were analyzed using generalized estimating equation (GEE) analyses and Cox regression, adjusting for all relevant covariables, with TPO-Abs analyzed as continuous and dichotomous variable. Main results and the role of chance Of 1,052 women attending the outpatient clinic and treated IUI, TPO-Abs were measured in 687 women. Among these, 115 (16.7%) were TPO-Abs positive and 572 (83.3%) TPO-Abs negative. Mean age was 35.7 years (SD 3.9). At baseline, TSH levels were slightly higher in TPO-Abs positive women compared with TPO-Abs negative women (2.6 ± 2.4 vs. 2.1 ± 1.5 mIU/L; p = 0.004). Following IUI, 234 women (34.0%) achieved an ongoing pregnancy: 40 in the TPO-Abs positive group (34.8%) and 194 in the TPO-Abs negative group (33.9%). Subsequently, 231 women proceeded to IVF/ICSI, of whom 90 (39.0%) achieved an ongoing pregnancy, including 16 TPO-Abs positive women (48.5%) and 74 TPO-Abs negative women (37.4%). Multivariable generalized estimating equation analyses showed no significant association between TPO-Abs and ongoing pregnancy after IUI (adjusted OR 0.72, 95% CI 0.44–1.18; p = 0.192) or miscarriage after IUI (adjusted OR 1.38, 95% CI 0.61–3.11; p = 0.440). Cox regression demonstrated no association between TPO-Abs and time to ongoing pregnancy across the entire treatment trajectory, including IUI and subsequent IVF/ICSI. Limitations, reasons for caution Due to the retrospective design, there is an inherent risk of selection bias. Thyroglobulin antibodies were not assessed, potentially leading to an underestimation of broader thyroid autoimmunity. In addition, missing data and losses to follow up may introduce further sources of bias, which may influence the robustness of the data. Wider implications of the findings Euthyroid infertile women with thyroid autoimmunity had similar IUI success, miscarriage risk, and overall time to pregnancy compared with women without thyroid autoimmunity. These findings suggest limited utility of TPO-Abs alone for predicting treatment success or guiding ART decisions in euthyroid infertile women. Trial registration number No
Zitieren
APA
Loendersloot, L. V., Klashorst, B. V. D., Wely, M. V., Delprat, C., Goddijn, M., Lambalk, N., Finken, M., Vergouw, C., & Mijatovic, V. (2026). L26/O-296 Impact of thyroid autoimmunity on reproductive outcomes after intra uterine insemination (IUI) and subsequent IVF/ICSI in euthyroid infertile women: a retrospective cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.294
Vancouver
Loendersloot LV, Klashorst BVD, Wely MV, Delprat C, Goddijn M, Lambalk N, et al. L26/O-296 Impact of thyroid autoimmunity on reproductive outcomes after intra uterine insemination (IUI) and subsequent IVF/ICSI in euthyroid infertile women: a retrospective cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.294
BibTeX
@article{Loendersloot2026,
author = {Loendersloot, L. Van and Klashorst, B. Van der and Wely, M. Van and Delprat, C. and Goddijn, M. and Lambalk, N. and Finken, M. and Vergouw, C. and Mijatovic, V.},
title = {L26/O-296 Impact of thyroid autoimmunity on reproductive outcomes after intra uterine insemination (IUI) and subsequent IVF/ICSI in euthyroid infertile women: a retrospective cohort study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.294}
}
EUVIMED